BELLEVUE, Clean.–(Organization WIRE)–Dec 23, 2021–
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-initial overall health and wellness by a multidisciplinary health care ecosystem of companies and solution innovation, nowadays announced that its wholly owned subsidiary, Novo Healthnet Limited, has been granted a Pure Product or service Selection (NPN) by Wellbeing Canada for IoNovo Iodine, a proprietary pure aqueous iodine micronutrient delivered in an oral or nasal spray structure for optimum influence and bioavailability. An NPN is a item license assessed and granted by Health Canada to commercialize a item that is observed to be harmless, successful, and of substantial excellent.
Novo’s latest acquisition of Terragenx Inc. has authorized the rapid commercialization of IoNovo Iodine, affording shoppers the next level of individual biosecurity with a simple and safe and sound, 100% pure products. Iodine is recognized as a environment course disinfectant and is one of nature’s best microbial killers of micro organism and virus deactivators. Iodine is an crucial micronutrient required for the human overall body to make specific thyroid hormones (T3/T4) that activate and reinforce our immune system.
IoNovo Iodine oral spray is 100% pure and purely natural with no chemical substances, no plastics, and no alcoholic beverages. IoNovo Iodine is a distinctive daily-use micronutrient developed to handle difficulties from the widespread chilly to COVID-19 and beyond.
About Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. is pioneering a holistic tactic to affected person-first wellbeing and wellness via a multidisciplinary healthcare ecosystem of solutions and merchandise innovation. Novo features an crucial and differentiated resolution to produce, or intend to supply, these solutions and solutions by means of the integration of health care technology, state-of-the-art therapeutics, and rehabilitative science.
We consider that “decentralizing” healthcare, as a result of the integration of clinical technologies and interconnectivity, is an important answer to the rapidly evolving essential transformation of how non-catastrophic healthcare is shipped each now and in the potential. Precise to non-critical treatment, ongoing developments in the two medical technological innovation and inter-connectivity are allowing for for a shift of the client/practitioner romantic relationship to the patient’s dwelling and absent from on-web page visits to key health care facilities with mass-services. This acceleration of “ease-of-access” in the individual/practitioner interaction for non-crucial care prognosis and subsequent remedy minimizes the degradation of non-essential well being problems to crucial disorders as properly as enabling for far more charge-productive healthcare distribution.
The Company’s decentralized healthcare enterprise model is centered on 3 key pillars to finest aid the transformation of non-catastrophic health care delivery to patients and shoppers:
- First Pillar: Service Networks. Deliver multidisciplinary major care expert services by (i) an affiliate community of clinic facilities, (ii) compact and micro footprint sized clinic services mainly found within just the footprint of box-retail store professional enterprises, (iii) clinic amenities operated by means of a franchise romantic relationship with the Enterprise, and (iv) company operated clinic facilities.
- Second Pillar: Know-how. Build, deploy, and integrate sophisticated interconnected know-how, interfacing the affected individual to the healthcare practitioner therefore growing the reach and availability of the Company’s providers, further than the traditional clinic location, to geographic regions not conveniently supplying superior, peripheral based health care services, like the patient’s home.
- Third Pillar: Solutions. Develop and distribute productive, individualized overall health and wellness item remedies making it possible for for the customization of patient preventative treatment therapies and eventually a much healthier population. The Company’s science-first tactic to product innovation even more emphasizes our mandate to create and supply over-the-counter preventative and servicing treatment remedies.
Innovation through science blended with the integration of refined, secure technologies assures Novo Built-in Sciences of ongoing cutting edge progression in affected individual initially platforms.
This press launch consists of forward-wanting statements within just the meaning of Portion 27A of the Securities Act of 1933, as amended, and Portion 21E of the Securities Trade Act of 1934, as amended. All statements other than statements of historical specifics integrated in this push launch are forward-on the lookout statements. In some cases, forward-hunting statements can be recognized by words this sort of as “feel,” “intend,” “be expecting,” “foresee,” “prepare,” “prospective,” “carry on” or related expressions. Such forward-hunting statements contain pitfalls and uncertainties, and there are essential things that could bring about actual results to differ materially from people expressed or implied by these ahead-wanting statements. These factors, challenges and uncertainties are talked over in Novo’s filings with the Securities and Trade Fee. Investors ought to not position any undue reliance on ahead-seeking statements given that they include acknowledged and unknown, uncertainties and other factors which are, in some conditions, outside of Novo’s command which could, and probable will, materially have an effect on real outcomes, concentrations of exercise, overall performance or achievements. Any forward-wanting statement demonstrates Novo’s recent views with respect to foreseeable future situations and is subject to these and other hazards, uncertainties and assumptions relating to operations, results of operations, growth approach and liquidity. Novo assumes no obligation to publicly update or revise these ahead-hunting statements for any motive, or to update the factors genuine results could differ materially from all those predicted in these ahead-searching statements, even if new information results in being offered in the foreseeable future. The contents of any site referenced in this press launch are not incorporated by reference herein.
Look at source version on businesswire.com:https://www.businesswire.com/information/property/20211223005093/en/
Call: Chris David, COO-President
Novo Built-in Sciences, Inc.
Search term: WASHINGTON UNITED STATES NORTH The united states CANADA
Market Search phrase: BIOTECHNOLOGY OTHER Overall health Overall health PHARMACEUTICAL Health-related Supplies
Supply: Novo Integrated Sciences, Inc.
Copyright Business Wire 2021.
PUB: 12/23/2021 08:00 AM/DISC: 12/23/2021 08:01 AM
Copyright Enterprise Wire 2021.